Internal Medicine, Infectious Disease · Tampa, FL
NPI
1962528828
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
4600 N Habana Ave, Suite 18
Tampa, FL, 33614
Phone (813) 875-6520
Medicare paid, 2024
$13K
152 services
Medicare patients, 2024
55
Average age 69
Drug cost, 2024
$6.1M
3,077 prescriptions
Company payments, 2025
$1,078
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan M Martinez was code 99214 (office e&m - established), 81 times for 36 patients. In total Juan M Martinez billed 152 services in 7 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 81 | 36 | $83.23 | $6,742 |
| 99232 Hospital E&M - Subsequent | Facility | 40 | 15 | $61.49 | $2,460 |
| 99222 Hospital E&M - Initial | Facility | 19 | 15 | $102.32 | $1,944 |
By year: 2022 $20K for 242 services; 2023 $14K for 161 services; 2024 $13K for 152 services.
Medicare prescription drug claims, 2024
In 2024, the drug Juan M Martinez prescribed most often to Medicare patients was Dovato (Dolutegravir Sodium/Lamivudine), with 802 prescriptions and refills. In total Juan M Martinez wrote 3,077 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dovato Dolutegravir Sodium/Lamivudine | 802 | 802 | 66 | $2.3M |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 396 | 396 | 34 | $1.5M |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 191 | 198 | 25 | $399 |
| Tivicay Dolutegravir Sodium | 188 | 188 | 16 | $412K |
| Descovy Emtricitabine/Tenofov Alafenam | 183 | 183 | 16 | $395K |
| Prezcobix Darunavir/Cobicistat | 149 | 149 | 13 | $347K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 120 | 120 | 12 | $537K |
| Valacyclovir Valacyclovir Hcl | 70 | 70 | Under 11 | $1,401 |
| Cyproheptadine Hcl Generic | 69 | 79 | Under 11 | $1,240 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 45 | 45 | Under 11 | $181K |
| Pregabalin Generic | 32 | 32 | Under 11 | $498 |
| Juluca Dolutegravir/Rilpivirine | 30 | 30 | Under 11 | $100K |
| Pantoprazole Sodium Generic | 28 | 39 | Under 11 | $108 |
| Pifeltro Doravirine | 27 | 27 | Under 11 | $45K |
| Gabapentin Generic | 27 | 27 | Under 11 | $357 |
Brand drugs: 2,003 claims; generic drugs: 1,062 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan M Martinez $1,078 ($1,078 in general payments such as food, travel and fees) from 6 companies. The largest payer was ViiV Healthcare Company with $323.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.